Related references
Note: Only part of the references are listed.Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect
Roberta Pece et al.
HAEMATOLOGICA (2022)
Carboxylic Acid Bioisosteres in Medicinal Chemistry: Synthesis and Properties
Kato Bredael et al.
JOURNAL OF CHEMISTRY (2022)
Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition
Doretta Cuffaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Acylhydrazones and Their Biological Activity: A Review
Laura-Ileana Socea et al.
MOLECULES (2022)
Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines
Susanna Nencetti et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Novel carbonic anhydrase inhibitors
Claudiu T Supuran
FUTURE MEDICINAL CHEMISTRY (2021)
Synthesis of Novel N-Acylhydrazones and Their C-N/N-N Bond Conformational Characterization by NMR Spectroscopy
Rubina Munir et al.
MOLECULES (2021)
Matrix Metalloproteinases: How Much Can They Do?
Magnus S. Agren et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms
Elisa Nuti et al.
CELLS (2020)
An overview of carbohydrate-based carbonic anhydrase inhibitors
Doretta Cuffaro et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Guo Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
ADAM Metalloproteinases as Potential Drug Targets
Caterina Camodeca et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP)
Doretta Cuffaro et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
N-Acylhydrazones as drugs
Sreekanth Thota et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies
Elisa Nuti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates
Doretta Cuffaro et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
Heng Li et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents
Xin-Wen Xie et al.
CHEMMEDCHEM (2017)
MMP Inhibitors: Past, present and future
Jillian M. Cathcart et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2015)
Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1 binding site
Hiroshi Nara et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1' Pocket in the Design of Selective, Small Molecule Inhibitors
Benjamin Fabre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach
Hiroshi Nara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogens
Cosimo G. Fortuna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Proteases involved in cartilage matrix degradation in osteoarthritis
Linda Troeberg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
Fragment-Based Discovery of Indole Inhibitors of Matrix Metalloproteinase-13
Steven J. Taylor et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
Mark E. Schnute et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
Paul C. D. Hawkins et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein
Baohe Tian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Joint diseases and matrix metalloproteinases: A role for MMP-13
Hironari Takaishi et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects
Adam R. Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Comparison of shape-matching and docking as virtual screening tools
Paul C. D. Hawkins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
NMR study of conformation and isomerization of aryl- and heteroarylaldehyde 4-tert-butylphenoxyacetylhydrazones
Victor V. Syakaev et al.
JOURNAL OF MOLECULAR STRUCTURE (2006)
New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2)
A Rossello et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
A specific mechanism of nonspecific inhibition
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Share Paper
